Quantcast

Latest Genodermatoses Stories

2014-07-23 08:30:17

CARLSBAD, Calif., July 23, 2014 /PRNewswire/ -- Essentialis announced today the receipt of a grant from the Foundation for Prader-Willi Research (FPWR) to support clinical study PC025, which is designed to evaluate the safety and efficacy of diazoxide choline controlled release tablets (DCCR) in obese Prader-Willi syndrome patients. The clinical study is being conducted at the University of California, Irvine under the direction of Dr. Virginia Kimonis. "We have found that the...

2014-07-13 23:02:51

The Living With KP book review that was just updated by Vkool.com reveals Jennifer Richards’ home treatment book that promises efficiency in treating keratosis pilaris. Seattle, Wa (PRWEB) July 13, 2014 According to the Living With KP book review recently updated by Vkool.com, this is a comprehensive guide that features a series of tips and advice on how to deal with KP (keratosis pilaris). This guide consists of 14 chapters including:     Chapter 1: What Is...

2014-06-27 08:24:40

CARLSBAD, Calif., June 27, 2014 /PRNewswire/ -- Essentialis announced today the dosing of the first patient in clinical study PC025, which is designed to evaluate the safety and efficacy of diazoxide choline controlled release tablets (DCCR) in obese Prader-Willi syndrome patients. "Although we are announcing today the dosing of the first patient, fully one third of the patients for the study have already been qualified and are scheduled for dosing and another third are currently...

2014-06-17 08:28:05

CARLSBAD, Calif., June 17, 2014 /PRNewswire/ -- Essentialis announced today the grant of its first patent in Japan (Patent number 5543110). The patent provides extensive protection to Essentialis' lead product, Diazoxide Choline Controlled-Release Tablet (DCCR). The claim scope covers the active in DCCR and a broad family of related actives, polymorphs of the active, methods of manufacture, all pharmaceutical formulations of the actives and methods of use of these pharmaceutical...

2014-06-12 08:28:59

DURHAM, N.C., June 12, 2014 /PRNewswire/ -- Scioderm, Inc. today announced the addition of Ronald Nardi, Ph.D. as the company's first chief scientific officer. Key points: -- Dr. Nardi brings more than 35 years of experience in drug discovery, development and regulatory affairs and was most recently the executive vice president of regulatory affairs and quality assurance at International Partnership for Microbicides. -- Dr. Nardi was previously the chief...

2014-05-28 08:30:01

CARLSBAD, Calif., May 28, 2014 /PRNewswire/ -- Essentialis announced today that the U.S. Food and Drug Administration's Office of Orphan Products Development has granted orphan drug designation to diazoxide choline, the patent protected active in DCCR for the treatment of Prader-Willi syndrome, a rare complex neurobehavioral/metabolic disease for which there is no FDA-approved therapy. Prader-Willi syndrome afflicts about 1 in 15,000 to 1 in 25,000 individuals, with the US...

2014-05-21 23:15:49

Banish My Bumps is a new method developed to help people get rid of Keratosis Pilaris quickly. The site hynguyenblog.com has written a full review to show whether this method is worth buying or not. New York, NY (PRWEB) May 21, 2014 Banish My Bumps is a newly updated keratosis pilaris (KP) method designed to help patients get rid of keratosis Pilaris quickly and safely. This new method guides people on how to heal KP without using any medication or pills. In addition, the method teaches...

2014-05-15 12:35:07

TORONTO, May 15, 2014 /CNW/ - The month of May is tuberous sclerosis complex (TSC) awareness month in Canada, and May 15(th) is TSC Global Awareness Day. During this time, the goal is to increase public awareness about this genetic disorder that causes tumours to form in vital organs, primarily in the brain, eyes, heart, kidneys, skin and lungs. It is also the leading genetic cause of both autism and epilepsy. 1 in 6000 children are born with TSC. Early detection and treatment is...

2014-05-15 08:33:43

Research initiative focused on developing improved treatments for tuberous sclerosis complex patients brings hope on TSC Awareness Day GRAND RAPIDS, Mich., May 15, 2014 /PRNewswire/ -- May 15(th) is Tuberous Sclerosis Complex Awareness Day, and in 2013 Van Andel Research Institute (VARI) launched the Pathway of Hope research initiative under the direction of Dr. Jeffrey MacKeigan, Associate Professor and Head of the Institute's Laboratory of Systems Biology. The initiative involves...

2014-05-14 00:21:38

SILVER SPRING, Md., May 14, 2014 /PRNewswire-USNewswire/ -- On May 15, the Tuberous Sclerosis Alliance (TS Alliance) will join tuberous sclerosis complex (TSC) organizations around the world to observe the third annual TSC Global Awareness Day. On this day, thousands of individuals and families affected by TSC will join together to increase public awareness of the rare disease and share their stories of hope for the future. This year's TSC Global Awareness Day will feature a social...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related